近视乐品牌怎么样 申请店铺

更新时间:2024-10-28
近视乐是哪个国家的品牌?「近视乐」是 大理白族自治州中药制药有限公司 旗下著名品牌。该品牌发源于云南省大理白族自治州,由创始人朱 * 在1969年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
近视乐怎么样

用大理地区主产的白族药紫坚伦为主要原料生产的近视乐眼药水业界知名,全国民族用品定点生产企业。

1969 年始建于云贵高原之南的具有 “ 风花雪月 ” 美称的大理白族自治州境内的大理白族自治州中药制药有限公司,前身是大理白族自治州中药制药厂。2002 年改制为由董事长控股经营的有限责任公司。

2003年12月通过GMP认证验收,企业占地15000 余平方米,达到GMP的净化生产车间1950平方米,仓库的建筑面积 8000 多平方米。企业信用等级经银行认定达 AA 级。企业现有在职员工近 200 人,退休职工 31 人,在职员工中有技术人员 36 人,其中有高级制药工程师 3 人,工程师级 15 人。

2008年12月顺利通过第二轮GMP认证验收。本次认证验收前我公司一方面又投入大量资金对厂房、设备进行改造、引进,第二方面着重对软件部分进行深入调整、改进,使之更加具有可操作性。

公司现有经国家药监局批准注册的国药准字号品种 43 个,分属于片剂、酊剂、滴眼剂、胶囊剂、糖浆剂、软膏剂、散剂、酒剂、颗粒剂九个剂型,产品注册商标为“巍”字牌。公司生产的专治青少年近视、假性近视和近距离用眼疲劳的、以用大理地区主产的白族药紫坚伦为主要原料生产的近视乐眼药水和专治甲肝、乙肝、脂肪肝等多种肝病的傣族药叶下珠片,也是公司的主要产品,目前已销到全国各地。其中近视乐眼药水为我公司的原研产品,已获得中药品种保护。

公司热忱欢迎海内外一切有志于发展中药制药事业的法人、自然人前来对现有产品进行投资合作生产、产品地区销售代理;进一步研制开发中成药系列新产品,做大做强我公司的中药制药事业。

Zijianlun, a Bai nationality medicine mainly produced in Dali area, is the main raw material for the production of myopic eye drops, which is well-known in the industry and a designated national product manufacturer. Founded in 1969 in the south of Yunnan Guizhou Plateau, Dali Bai Autonomous Prefecture traditional Chinese Medicine Pharmaceutical Co., Ltd., formerly known as Dali Bai Autonomous Prefecture traditional Chinese medicine pharmaceutical factory, enjoys the reputation of "wind, flowers, snow and moon". In 2002, it was restructured into a limited liability company controlled by the chairman of the board of directors. In December 2003, the company passed the GMP certification and acceptance, covering an area of more than 15000 square meters, reaching the GMP purification workshop of 1950 square meters, and the warehouse building area of more than 8000 square meters. The credit rating of the enterprise has been recognized by the bank as AA. At present, the company has nearly 200 employees and 31 retired employees, 36 of whom are technicians, including 3 senior pharmaceutical engineers and 15 engineers. In December 2008, it successfully passed the second round of GMP certification acceptance. Before this certification and acceptance, our company on the one hand invested a lot of funds in the transformation and introduction of plant and equipment, on the other hand, focused on the in-depth adjustment and improvement of the software to make it more operable. At present, the company has 43 kinds of state drug approved and registered by the State Food and drug administration, which are divided into nine dosage forms: tablet, tincture, eyedrop, capsule, syrup, ointment, powder, liquor and granule. The registered trademark of the product is "Wei" brand. The company's main products are myopic eye drops, which are mainly made of zijianlun, a Bai nationality medicine produced in Dali, and ye Xiazhu tablets, which are also the company's main products, which are specialized in treating juvenile myopia, pseudomyopia and near-range eye fatigue. At present, they have been sold all over the country. Among them, myopic eye drops are the original research products of our company, which have been protected by traditional Chinese medicine. The company warmly welcomes all legal persons and natural persons at home and abroad who are willing to develop the pharmaceutical industry of traditional Chinese medicine to come to invest and cooperate in the production of existing products, and to sell and act as sales agents in product areas; to further develop new products of traditional Chinese medicine series, and to make our company's pharmaceutical industry of traditional Chinese medicine bigger and stronger.

本文链接: https://brand.waitui.com/d9640a022.html 联系电话:0872-6120915,6120950

千城特选小程序码

7×24h 快讯

上交所终止如鲲新材科创板发行上市审核

36氪获悉,据上交所,因上海如鲲新材料股份有限公司及其保荐人东方证券股份有限公司撤回发行上市申请,上交所终止其科创板发行上市审核。

27分钟前

万华化学:第三季度营收505.37亿元,同比增长12.48%

36氪获悉,万华化学发布第三季财报。财报显示,第三季度营收为505.37亿元,同比增长12.48%;净利润为29.19亿元,同比下降29.41%。前三季度营收为1476.04亿元,同比增长11.35%;净利润为110.93亿元,同比下降12.67%。

27分钟前

新安股份:控股子公司拟1.9亿元收购传化嘉易100%股东权益

36氪获悉,新安股份公告,公司控股子公司华洋化工拟出资1.9亿元,收购传化智联持有的传化嘉易100%股东权益。本次收购传化嘉易100%股权旨在解决制约控股子公司华洋化工发展战略的瓶颈问题,有利于其扩大生产规模,升级产品工艺,增强新产品的研发生产能力。本次交易构成关联交易,交易对方传化智联为公司控股股东传化集团的控股子公司。

27分钟前

南网储能:第三季度营业收入45.19亿元,同比增长11.12%

36氪获悉,南网储能发布2024年第三季度财报。报告显示,公司前三季度实现营业收入45.19亿元,同比增长11.12%;归属于上市公司股东的净利润10.45亿元,同比增长27.62%。第三季度实现营业收入16.08亿元,同比增长33.33%;归属于上市公司股东的净利润4.19亿元,同比增长231.49%。

27分钟前

上周无新增IPO申报企业

36氪获悉,上周(10月21日—10月27日)无新增IPO申报企业。截至10月27日,今年新增IPO申报企业35家。截至10月27日,各板块在审企业共277家。其中上交所77家(主板52家,科创板25家),深交所111家(主板36家,创业板75家),北交所89家。

27分钟前

本页详细列出关于近视乐的品牌信息,含品牌所属公司介绍,近视乐所处行业的品牌地位及优势。
咨询